23560911000001108: Vilanterol (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

76917701000001116 Vilanterol (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

76917801000001113 Vilanterol en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Vilanterol	Is a	Substance with beta-2 adrenergic receptor agonist mechanism of action	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler	Has specific active ingredient	False	Vilanterol	Inferred relationship	Existential restriction modifier
Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler	Has specific active ingredient	False	Vilanterol	Inferred relationship	Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd)	Has specific active ingredient	False	Vilanterol	Inferred relationship	Existential restriction modifier
Relvar Ellipta 92micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd)	Has specific active ingredient	False	Vilanterol	Inferred relationship	Existential restriction modifier
Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose	Has specific active ingredient	False	Vilanterol	Inferred relationship	Existential restriction modifier
Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose	Has specific active ingredient	False	Vilanterol	Inferred relationship	Existential restriction modifier
Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) 30 dose	Has specific active ingredient	False	Vilanterol	Inferred relationship	Existential restriction modifier
Relvar Ellipta 92micrograms/dose / 22micrograms/dose inhaler (GlaxoSmithKline UK Ltd) 30 dose	Has specific active ingredient	False	Vilanterol	Inferred relationship	Existential restriction modifier
Vilanterol trifenatate	Is a	False	Vilanterol	Inferred relationship	Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	False	Vilanterol	Inferred relationship	Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	False	Vilanterol	Inferred relationship	Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	False	Vilanterol	Inferred relationship	Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	False	Vilanterol	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets